Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Teladoc a Better Buy than Amwell?

TheMotleyFool

0 0

Telehealth giant Teladoc (NYSE: TDOC) has seen its shares dip considerably in recent months, but the business is stronger than ever. In this segment of Backstage Pass, recorded on Jan. 12, Fool contributor Rachel Warren responds to a member's question about the company and one of its most well-known competitors, Amwell (NYSE: AMWL).

Source Fool.com

Like: 0

TDOC

Share